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ABSTRACT:Brain endothelial cells constitute themajor cellular element of the highly specializedblood–brainbarrier
(BBB) and thereby contribute to CNS homeostasis by restricting entry of circulating leukocytes and blood-borne
molecules into the CNS. Therefore, compromised function of brain endothelial cells has serious consequences for
BBB integrity. This has been associated with early events in the pathogenesis of several disorders that affect the
CNS, such as multiple sclerosis, HIV-associated neurologic disorder, and stroke. Recent studies demonstrate that
brain endothelial microRNAs play critical roles in the regulation of BBB function under normal and neuro-
inflammatory conditions. This review will focus on emerging evidence that indicates that brain endothelial
microRNAs regulate barrier function and orchestrate various phases of the neuroinflammatory response, including
endothelial activation in response to cytokines aswell as restoration of inflamed endothelium into a quiescent state.
In particular, we discuss novel microRNA regulatory mechanisms and their contribution to cellular interactions at
the neurovascular unit that influence the overall function of the BBB in health and during neuroinflammation.
—Lopez-Ramirez, M. A., Reijerkerk, A., de Vries, H. E., Romero, I. A. Regulation of brain endothelial barrier
function by microRNAs in health and neuroinflammation. FASEB J. 30, 2662–2672 (2016). www.fasebj.org
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INTRODUCTION
Brain endothelial cells (BECs) constitute the major cellular
element of the highly specialized blood–brain barrier (BBB)
that is essential for CNS homeostasis. The cerebral micro-
vasculature formed by BECs constitutes an elaborate net-
workofvessels that is composedof arterioles (10–100mmin
diameter), capillaries (4–10 mm in diameter), and venules
(10–100 mm in diameter), which allows transport of nutri-
ents and gases and removal of waste products throughout
the brain and spinal cord (1). Of note, BECs play an im-
portant role inmaintainingblood flowand limiting entry of
circulating leukocytes and blood-borne molecules into
the CNS. In mammals, BECs are unique and differ from
endothelial cells that are present in peripheral tissues in a
number of ways, which ensures specific brain endothelial
barrier properties. First, BECs have fewpinocytotic vesicles
and lack fenestrations that are typical of peripheral tissue
capillaries. Second, BECs have a high number of mito-
chondria, which suggests elevated metabolic activity.
Third, BECs form a metabolic barrier by containing sev-
eral catalytic membrane-bound and cytosolic enzymes
that are capable of regulating metabolism of endogenous
and xenobiotic molecules (2, 3). Fourth, BECs allow im-
mune surveillance of the CNS, thereby playing a funda-
mental role in host defense withminimal inflammation (4).
Fifth, BECs are the gatekeeper of the CNS as a result of an
elaborate systemof transportproteins and ion channels that
are present in the plasma membrane and are asymmetri-
cally distributed on the luminal (blood-facing) and ablu-
minal (brain- and spinal cord–facing) sides, which allows
bidirectional transport of selected substances (1, 2, 5). Of
importance, BECs are interconnected by complex tight
junctions (TJs) between lateral plasma membranes, which
results in a polarized insertion of lipids and proteins (fence
function). In turn, this feature restrictsparacellulardiffusion
of nonionic hydrophilic molecules and ionic molecules,
and, consequently, confers BECs a high electrical resistance
(;3000V·cm2 in vivo; barrier function) (6, 7).
The BBB is regulated and induced by the CNS-specific
microenvironment, which leads to the emerging concept
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that the complex cellular structure known as the neuro-
vascular unit is what determines its specialized function.
The neurovascular unit includes dynamic communication
and feedbacknetworks betweenvarious cell types, suchas
BECs,pericytes, astrocytes,perivascularmicroglia, smooth
muscle cells, and neurons, as well as the extracellular ma-
trix, so that it may respond to physiological changes and
function as a biological barrier (8, 9). It is noteworthy that
gene expression programs that underline the unique brain
endothelial phenotype and function are highly regulated
andunder the control of theCNSmicroenvironmentunder
physiological conditions (10). Indeed, the complexityof the
cerebrovascular network requires coordinated genetic
programs that, in part, are controlled by transcriptional
activity [for a review, see Minami and Aird (11)] and, in
part, by chromatin remodeling [for a review, see Matouk
and Marsden (12)]. Recent studies have proposed post-
transcriptional gene regulation, mediated via small non-
codingRNAs termedmicroRNAs, as apossiblemechanism
that integrates the CNS milieu and BEC phenotype and
function. In this context, microRNAs would contribute to
the fine tuningof the complex regulatorygenenetworks of
BECsunderphysiological andpathological conditions (13,
14). Moreover, it has become evident that many aspects of
BEC biology, such as angiogenesis, neuroinflammation,
and barrier function, are regulated bymicroRNAs. Recent
research has been carried out in the context of stroke (15),
and this is extensively reviewed in Yin et al. (16). It is also
worth mentioning that endothelial microRNAs regulate
the permeability of the blood–tumor barrier (17, 18) and
destabilize TJs in CNS tumor metastasis (19). In this re-
view, we discuss brain endothelial microRNA regulatory
mechanisms and their contribution to BBB function under
both physiological and pathological states, in particular,
those related to neuroinflammation.
BRAIN ENDOTHELIAL microRNA FAMILIES AND
THEIR ROLES IN NEUROINFLAMMATION
To better understand the physiology of microRNAs, bio-
informaticians have grouped microRNAs into broadly con-
served families on the basis of sequence and structure
similarity of pre-microRNAs; therefore, microRNA families
can exhibit full or partial conservation amonganimal species
on the 2–8 mature microRNA sequence (20, 21). Experi-
mental studiesdemonstrate thatmicroRNAfamilymembers
execute conserved biological functions across species (22).
Our recent studies of microRNA expression in the
brain endothelium, using conditions known to nega-
tively modulate BBB function (13, 23, 24), revealed pro-
found changes in the brain endothelialmicroRNAprofile
(Table 1) (13). Of these changes, several microRNA
families with roles in cardiovascular biology seemed to
be critically affected by cytokine treatment (Table 2). For
instance, microRNA-30, microRNA-125, and let-7 fami-
lies were remarkably negatively regulated by proin-
flammatory cytokines (Table 2). It is noteworthy that
decreased expression of microRNA-30 family members
has been associated with loss of cell adhesion, changes in
cellmorphology, and increased cellmigration in epithelial
cells by modulation of snai-1 (25), a transcription factor
that silences genes that are important for TJ and adherens
junction formation and stability by interacting with E-box
sequences (26–28). In endothelial cells, members of the
microRNA-30 family regulate vascular development and
sprouting in angiogenesis by targeting the notch ligand,
delta-like ligand 4 (29). Thus, members of the microRNA-
30 family represent potential targets, with roles in modu-
lationofcell-to-cell contacts, and,asaconsequence,possibly
barrier function in the brain endothelium; however, the role
of microRNA-30 family in the regulation of BBB function
in vivo remains to be elucidated.
Members of microRNA-125 family have been shown to
play common roles that are associated with induced cell
proliferation and decreased apoptosis by targeting proa-
poptoticgenes;however,otherbiological effectsbymembers
ofmicroRNA-125 family have also been reported (30). In the
context of brain endothelium, we recently reported that
microRNA-125a-5p supports immune quiescence and en-
dothelial barrier function (13). Our study demonstrated that
during neuroinflammation, expression of brain endothelial
microRNA-125a-5p is suppressed, resulting in increased
monocyte migration as a result of endothelial up-regulation
of intercellular cell adhesion molecule 1 (ICAM-1) (13). In
addition, members of microRNA-125 family can modulate
angiogenesisby targeting transcription factors.Repressionof
microRNA-125a/b promotes angiogenesis, whereas over-
expression of microRNA-125a/b impairs angiogenesis by
targeting related transcriptional enhancer factor-1 and VE-
cadherin (31, 32) in endothelial cells. MicroRNA-125b has
also been shown to regulate glioma-associated angiogen-
esis.Mechanistically, brain endothelial microRNA-125b
is suppressed by the glioblastomamicroenvironment, and
VEGF stimuli resulted in increased expression levels of its
target myc-associated zinc finger protein, which is a tran-
scription factor that regulates the expression of VEGF (33).
The let-7 family is anothermicroRNA family that has
been shown to support brain endothelial barrier func-
tion and quiescent state (34). The proinflammatory cy-
tokine, TNF-a, decreased levels of let-7 familymembers
microRNA-98 and let-7g-3p (let-7g*) in brain endothe-
lium, which in turn increases monocyte cell adhesion
and migration in vivo (34).
In summary, proinflammatory cytokines affect several
families of brain endothelial microRNAs that have im-
portant roles in BBB function and in angiogenesis; how-
ever, it remains to be elucidated whether these families of
microRNAs cooperate during neuroinflammation and
whether they forma link between neuroinflammation and
angiogenesis in diseases that affect the CNS.
BRAIN ENDOTHELIAL microRNA CLUSTERS AND
THEIR REGULATION BY
PROINFLAMMATORY CYTOKINES
More than half of all currently known microRNA genes
are linked as clusters on chromosomes and are often
transcribed as a single polycistronic transcript, possibly
to provide the opportunity for different microRNAs to
simultaneously target different genes in specific cellular
pathways (35, 36). Moreover, clustered microRNAs may
have similar seed sequences, thereby sharing common
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gene targets (37). Our previous study shows that
proinflammatory cytokines alter the levels of 2 impor-
tant microRNA clusters in BECs, microRNA-17 and
microRNA-221 clusters, both of which have been asso-
ciated with several biological processes in endothelium
(Table 2) (13). Certainly, one of the most studied clusters
is the microRNA-17 cluster, which is formed by 6
members situated on chromosome 13 (37–40). Several
members of the microRNA-17 cluster may have related
functions and act as proangiogenic signals by silencing
antiangiogenic genes, such as thrombospodin-1 and
connective tissue growth factor, thereby leading to en-
hanced neovascularization (41). In addition, microRNA-
17 cluster has also been shown to regulate cell sprouting
and proliferation by inhibiting tissue inhibitor of
metalloproteinase-1 (40, 42, 43); however, using ische-
mia animal models, it has been demonstrated that
endothelial-specific conditional and forced overexpression
ofmicroRNA-19 andmicroRNA-92a, bothmembers of the
microRNA-17 cluster, negatively regulates ischemia-
induced arteriogenesis (44, 45). These studies suggest
that the microRNA-17 cluster might act either as a pos-
itive or negative regulator of angiogenesis depending on
the cell environment.
Finally, microRNA-221 cluster and family are highly
conserved in vertebrates (37). The microRNA-221
cluster regulates endothelial cell proliferation, migra-
tion, and capillary tube formation by targeting c-Kit
(46). In addition, microRNA-221 cluster has been
shown to indirectly modulate eNOS expression levels
(47, 48), and might be implicated in endothelial cell fate
commitment and cytoskeleton remodeling by targeting
the Cip/Kip family of proteins (39). It should be stated
that microRNA-125 and microRNA-221 might have
complementary actions. Depletion of the microRNA-
221 cluster indirectly reduced microRNA-125 expres-
sion in HUVECs (49). Moreover, ICAM1 is targeted by
the microRNA-221 cluster, and decreased levels of this
microRNA cluster result in up-regulation of ICAM1
protein expression in epithelial cells (50, 51).
Although proinflammatory cytokines induce alter-
ations in brain endothelial microRNA cluster expression
(13),whether this ismediated at the transcriptional level or
by modulation of microRNA processing remains unclear.
BRAIN ENDOTHELIAL microRNAs REGULATE
DIFFERENT PHASES OF THE
NEUROINFLAMMATORY RESPONSE
The cerebral microvasculature plays a major role in the
regulation of several phases of the neuroinflammatory
response, including vascular permeability, leukocyte ad-
hesion and migration, and restoration of activated endo-
thelium back to a quiescent state. Indeed, the process of
neuroinflammation requires a coordinated activation of
immune cells, brain resident cells, andCNSvasculature to
avoid collateral damage and unnecessary chronic in-
flammation. Depending on the strength and duration of
inflammatory stimuli, brain endothelial microRNAsmay
either change the genetic program toward an activated
inflamed vascular endothelium or regulate genes to
counteract cytokine signaling to return to a quiescent
state. Details of brain endothelial microRNAs that have
been shown to regulate inflammation as well as their
possible implication in regulating phases of the neuro-
inflammatory response have been summarized in the
next and following sections.
TABLE 2. Human microRNA families and clusters in the BEC cell line hCMEC/D3
miR represented Members Chromosome
Number of
members
Expressed in
hCMEC/D3 cells
Family
miR-30 miR-30a, miR-30b, miR-30c-1, miR-30c-2, miR30d, miR-30e NA 6 6
miR-130 miR-130a, miR-130b, miR-301a, miR-301b NA 4 4
miR-221 miR-221, miR-222 NA 2 2
miR-27 miR-27a, miR-27b NA 2 2
let let-7a-1, let-7a-2, let-7a-3, let-7b, let-7c, let-7d (NE), let-7e, let-7f-1, let-7f-2,
let-7g, let-7i, miR-98
NA 12 11
miR-125 miR-125a, miR-125b-1, miR-125b-2 NA 3 3
miR-19 miR-19a, miR-19b-1, miR-19b-2 NA 3 3
miR-148 miR-148a (NE), miR-148b, miR-152 NA 3 2
miR-181 miR-181a-1, miR-181a-2, miR-181b-1, miR-181b-2, miR-181c, miR181d NA 6 6
Cluster
miR-17 miR-17, miR-18a, miR-19a, miR-19b-1, miR-20a, miR-92a-1 13 6 6
miR-221 miR-221, miR-222 X 2 2
miR-125a let-7e, miR-99b, miR-125a 19 3 3
let-7a let-7a-1, let 7d (NE), let-7f-1 9 3 2
miR-130b miR-130b, miR-301b 22 2 2
miR-30d miR-30b, miR-30d 8 2 2
miR-23a miR-23a, miR-24-2, miR-27a 19 3 3
miR-23b miR-23b, miR-24-1, miR-27b, miR-3074 (NE) 9 4 3
Families and clusters were considered deregulated when levels of microRNA members changed$2 (italics) in the presence of TNF-a + IFN-g
(13). [Analysis was performed by using miRbase (http://www.mirbase.org) and miRfocus (http://pepcyber.org/mirfocus/ ) databases.] Some microRNAs
with high sequence similarity (underlined) could not be distinguished by the array analysis and were considered as one. miR, microRNA; NA, not
applicable; NE, not expressed.
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BRAIN ENDOTHELIAL microRNAs THAT
PROMOTE CELL ACTIVATION
IN NEUROINFLAMMATION
MicroRNA-155 promotes inflammation and activates
both immune cells and brain endothelium by silencing
hundreds of transcripts with modest effects, a character-
istic of fine tuning regulation (14, 52, 53). MicroRNA-155
originates from an exon in a noncoding transcript, B-cell
integration cluster, which is located on chromosome
21q21 (54). MicroRNA-155 is highly conserved in the an-
imal kingdom, including mammals, chicken, lizards,
zebrafish, and frogs (21, 55). Inflammatory mediators,
such as bacterial LPS, polyriboinosinic-polyrobocytidylic
acid, and TNF-a, induce expression of microRNA-155 in
several cell types, including the brain endothelium (14,
56–58). Inhibitors of JNK, PKC, and RhoA prevent
microRNA-155 up-regulation in macrophages, B cells,
T cells, epithelial cells, and BECs, and prevent their ability
to respond to immune challenge (59–61) (unpublished
observation). In the brain endothelium, microRNA-155
seems to be an important control node for expression and
organizationofadhesionmoleculesaswell as for inducing
a gene expression program characteristic of inflammation
(Table 3) (14). For instance, both treatment with TNF-a
and IFN-g and overexpression of microRNA-155 in BECs
induce expression of genes associated with immune re-
sponse, major histocompatibility complex, cell adhesion
molecules, and the complement system, pathways that
are known to contribute to the inflammatory response (14,
62, 63). It is possible that microRNA-155 up-regulation in
both immune cells and brain endothelium during neuro-
inflammation contributes to the harmonization of cell
activation as a mechanism of defense of the CNS against
pathogens; however, sustained and prolonged increases
in microRNA-155 levels in the brain endothelium may
provoke brain endothelial barrier breakdown by altering
components of the cell–cell and cell–extracellular matrix
adhesion pathways, both important cellular processes
that stabilize barrier function (14). Indeed, we demon-
strated that brain endothelial microRNA-155 is up-
regulated by proinflammatory cytokines in a time- and
dose-dependent manner (14). This response coincides
with cytokine-mediated increases in brain endothelial
barrier permeability that is associated with redistribution
of ZO1 at cell–cell contacts and with focal adhesion re-
organization. Functional analysis ofmicroRNA-155 in the
brain endothelium shows that this microRNA dampened
the expression of 2 interendothelial junctional complex
molecules, annexin-2 and claudin-1, and 2 focal adhesion
components, dedicator of cytokinesis-1 and syntenin-1,
which suggests an important mechanism by which
microRNA-155 exacerbates BBB breakdown (14).
Nevertheless, protective roles for microRNA-155 have
alsobeen suggested tooccur in different cell systems. Two
independent research groups have proposed that, in
resting conditions, microRNA-155 targets caspase-3, Fas-
associated death domain–containing protein, IKKe, and
the receptor-interacting serine-threonine kinase-1 to
maintain homeostasis and low levels of cell death (64, 65).
These results suggest that microRNA-155 might not only
act as a positive regulator of inflammation but can nega-
tively regulate activation of inflammatory pathways as
well, which may be dependent on the cellular context
and/or strengthanddurationof the stimuli. In the context
of endothelial cells, microRNA-155 may indeed modu-
late a number of biological processes. For instance,
microRNA-155 has been shown to be involved in regu-
lation of blood pressure and endothelial-dependent vaso-
relaxation bymodulating expression of angiotensin II type
1 receptor and eNOS expression (59), respectively (66–68).
Other groups recently described effects of microRNA-155
on endothelial cells, including modulation of the micro-
circulatoryvascular toneby targetingendothelin-1 (69)and
actomyosin contractility by targeting RhoA and myosin
light-chain kinase (70).
BRAIN ENDOTHELIAL microRNAs THAT
INHIBIT INFLAMMATION
MicroRNA-146a/b
Thehumangenomecontains 2membersof themicroRNA-
146 family, microRNA-146a (chromosome 5q34) and
microRNA-146b (chromosome 10q24), that are regu-
lated by proinflammatory cytokines (Table 1) (71).
MicroRNA-146a and microRNA-146b are coded from
noncoding transcripts units (71). The microRNA-146
family seed sequence is evolutionary conserved (21) but
the mature forms of microRNA-146a and microRNA-
146b differ by 2 nucleotides at the 39 region (71) that
might play a role in compensatory target recognition
(72). In the context of their physiological roles,
microRNA-146a and microRNA-146b are positively
regulated in immune cells bymicrobial components and
proinflammatory cytokines and function as negative
feedback regulators of inflammatory response (71).
Pharmacologic studies suggest that cytokine-induced
microRNA-146a is dependent on NF-kB and JNK-1/2
activity, whereas increased levels ofmicroRNA-146b are
mediated by MEK-1/2 and JNK-1/2 (73). Similar to im-
mune cells, brain endothelial microRNA-146 seems to be
an inhibitor of the activated state of the endothelium
during neuroinflammation (74, 75). The molecular
mechanism that underlies this biological process in BECs
and in immune cells include a negative feedback regu-
latory loop on NF-kB signaling by silencing IL-1
receptor–associated kinase 1/2 and TNF receptor–
associated factor 6 protein genes (71, 74–77). We also
observed that brain endothelial microRNA-146 re-
presses nuclear factor of activated T cells 5 and the
RhoGTPase RhoA, which, in turn, prevents NF-kB nu-
clear translocation and activity (74). Gain- and loss-of-
function analysis of microRNA-146 in BECs during
inflammation in vitro shows that this microRNA sup-
presses Jurkat T-cell adhesion to the brain endothelium
as a result of indirect inhibitory effects on protein levels
of the cell adhesionmolecule, VCAM1, and a chemokine
implicated in mononuclear cell infiltration, chemokine
ligand 2 (CCL2) (74). Altogether, these studies support a
role for brain endothelial microRNA-146 as a molecular
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TABLE 3. Up-regulation of mRNA transcripts in hCMEC/D3 cells after overexpression of microRNA-155
Term Count % P Genes
List
total
Fold
enrichment Bonferroni Benjamini
Immune response 53 1.61 9.85E-16 IFI44L, HLA-DMA, IL10, NOD2,
HLA-H, EXOSC9, SP100,
LY96, TNFRSF14, HLA-E,
HLA-G, PDCD1LG2, HLA-F,
IL18BP, TNFSF13B, HLA-
DPA1, GBP4, GBP2, GBP1,
PSMB10, IFIH1, IFITM2,
IFITM3, RSAD2, OAS1, C1R,
OAS2, CX3CL1, C1S, CCL5,
CD74, IFI35, GCH1,
TNFRSF1B, FCN3, SQSTM1,
TAP2, TAP1, DHX58, IL18R1,
IL1RL1, CFB, TRIM22,
PSMB8, PSMB9, DDX58,
TNFSF10, OASL, PLCG2,
C1RL, TGFBR3, IFI6, DMBT1
290 3.583128436 1.90E-12 1.90E-12
Response
to virus
19 0.58 1.47E-11 IFIH1, RSAD2, IFI44, IFI16,
STAT1, CCL5, TRIM22, IFI35,
ISG20, STAT2, DDX58, IRF9,
PLSCR1, ISG15, IRF7,
EIF2AK2, MX1, MX2, DMBT1
290 8.131350838 2.79E-08 1.40E-08
Host–virus
interaction
21 0.64 6.68E-07 PSMB10, CFLAR, IFIH1, SP100,
HTATIP2, TNFRSF14, SP110,
STAT1, TRIM22, PSMB8,
PSMB9, STAT2, ISG15, CD93,
ITGA5, TAP2, IRF7, TAP1,
RBCK1, EIF2AK2, DMBT1
369 3.840964199 2.47E-04 6.17E-05
Nucleosome 11 0.34 7.38E-07 H1F0, HIST1H2AC,
HIST2H2AA3, HIST1H2BD,
HIST1H1C, HIST1H2BK,
HIST2H2BE, HIST2H2AC,
HIST3H2A, H2AFJ, HIST1H4H
272 8.205065359 1.85E-04 1.85E-04
Antigen
processing and
presentation
12 0.37 1.44E-06 HLA-H, TAP2, IFI30, HLA-
DPA1, HLA-E, TAPBPL, HLA-
DMA, CD74, PSMB8, HLA-G,
PSMB9, HLA-F
290 6.74432904 0.002730866 5.47E-04
Histone core 9 0.27 2.90E-06 HIST1H2AC, HIST2H2AA3,
HIST1H2BD, HIST1H2BK,
HIST2H2BE, HIST2H2AC,
HIST3H2A, H2AFJ,
HIST1H4H
338 9.85739645 0.001916069 0.001916069
Chromatin
assembly
11 0.34 1.59E-05 H1F0, HIST1H2AC,
HIST2H2AA3, HIST1H2BD,
HIST1H1C, HIST1H2BK,
HIST2H2BE, HIST2H2AC,
HIST3H2A, H2AFJ,
HIST1H4H
290 5.898057868 0.029684206 0.003759627
DNA replication,
recombination,
and repair
10 0.30 4.06E-05 DDX58, IFIT1, IFIH1, DDX60,
PRIC285, POLQ, MMRN1,
DHX58, DHX32, TOP3B
49 5.527210884 6.90E-04 6.90E-04
Peptide transport 4 0.12 2.30E-04 SLC15A1, TAP2, TAP1, SLC15A3 369 29.7870693 0.08124383 0.010535918
Lysosome 11 0.34 6.03E-04 HYAL1, CD68, LAMP3, GUSB,
IFI30, ACP2, SLC15A3, HLA-
DMA, CD74, CTSL1, GLB1
369 3.848329423 0.199669631 0.022026854
Cell adhesion
molecules
8 0.24 0.038480818 ICAM2, PECAM1, HLA-DPA1,
HLA-E, HLA-DMA,
PDCD1LG2, HLA-G, HLA-F
123 2.505543237 0.990624458 0.404795422
Complement and
coagulation
cascades
5 0.15 0.082928761 CFB, SERPINA5, TFPI, C1R, C1S 123 2.995758218 0.999966429 0.52090005
Identiﬁed up-regulated gene transcripts determined by microarray (Illumina HumanRef-8, v3.0; Illumina, Inc., San Diego, CA, USA) analysis
after overexpression of microRNA-155 (using 30 nM pre-microRNA-155) in hCMEC/D3 cells (14). Analysis was performed by using DAVID
Bioinformatics (https://david.ncifcrf.org) (98). All genes with a small but signiﬁcant fold change in mRNA levels (.1.17-fold increase) were
included in the analysis above; analysis from 3 independent biological replicates. P , 0.01.
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break during the neuroinflammatory response to har-
monize a gradual down-regulation of inflammatory
signal in brain endothelium.
In prostate carcinoma cells, microRNA-146 regulates
the expression of Rho kinase 1 (78), a key mediator in
endothelial stress fiber formation and contractility that
precedes cell–cell junction delocalization and increased
barrier leakage during inflammation (79). However, brain
endothelial microRNA-146 does not affect Rho kinase 1
protein levels during neuroinflammation (74), which
suggests thatmicroRNA-146 confers accuracy in response
in a cell type–specific manner. Moreover, consistent with
a role for endothelial microRNA-146 as a negative regu-
lator of NF-kB signaling by repressing multiple targets,
overexpression of microRNA-146 in endothelial cells
negatively regulates the thrombin-induced increase in
leukocyte adhesion to the endothelium by targeting cas-
pase recruitment domain family 10 (80, 81), a key scaf-
fold protein of GPCR-mediated NF-kB signaling (80).
In addition, a recent study demonstrated that endothe-
lial microRNA-146 participates in the resolution of
cytokine-induced activated endothelium. Indeed, Cheng
et al. (75) demonstrated that whereas microRNA-146a
and microRNA-146b transcript (pri-microRNA-146a/b)
expression occurs early after treatment with proin-
flammatory cytokine IL-1b, themature forms,microRNA-
146a/b, did not increase until after long-term treatment
with IL-1b, which coincides with the resolution of in-
flamed endothelium into a quiescent state. Mechanisti-
cally, endothelial microRNA-146 post-transcriptionally
regulates RNA binding protein HuR, a protein that is in-
volved inendothelial activationand leukocyte recruitment
in response to the proinflammatory cytokine IL-1b (75).
MicroRNA-126/microRNA-126-5p
MicroRNA-126 andmicroRNA126-5p are highly enriched
in endothelial cells and play key roles in endothelial in-
tegrity and function (82, 83). Cytogenic location of
microRNA-126 and microRNA-126-5p is on chromosome
9q34.3, and both originate from an intron of the gene that
codes for epidermal growth factor–like-7 (Egfl7) (82–84).
Expression of microRNA-126 has also been detected in the
hematopoietic system, including bone marrow stem cells,
bone marrow samples from patients with acute promye-
locytic leukemias (85), and CD4+ cells of patients with
multiple sclerosis (MS) (86).MicroRNA-126 has beenmore
extensively studied than microRNA-126-5p and has been
implicated inseveral importantaspectsofvascularbiology,
including cell migration, cytoskeletal organization, capil-
lary formation, and vascular inflammation (43, 87). Func-
tional roles of microRNA-126 were first reported by using
knockout animalmodels that showed their essential role in
bloodvessel formationand integrity (82, 83). Indeed,before
these studies, it was observed that Egfl7-knockout pheno-
typewas associatedwith failure in angiogenesis and blood
vessel sprouting and formation, and only 50% of embryos
survived in utero (88); however, selective floxed Egfl7D
(removal of exon 5–7 without disruption of microRNA-
126) andmicroRNA-126D (removal of a segment of intron
7 without disruption of Egfl7) alleles demonstrated that
Egfl7D/D mice were phenotypically normal, whereas
microRNA-126D/D mice presented abnormalities in the
vasculature (83, 84) similar to those previously reported
after complete removal of Egfl7 (88). Phenotypic abnor-
malities inmicroRNA-126-knockoutmice include lethality
in ;50% of embryos because of loss of vascular integrity
(remarkably in the brain) accompanied by edema and
hemorrhage (83, 84). Surviving mutant neonates showed
defects in endothelial sprouting, proliferation, radial mi-
gration, and angiogenesis, leading to defective retinae
vascularization and cardiac neovascularization after
myocardial infarction (83, 84). It has been suggested that
the partial lethality of the microRNA-126 mutant mice
might be a result of modulation of the gene expression
program in endothelial vascularization, rather than a
complete shut-down of the angiogenic process (83). In-
deed, microRNA-126 has been shown to regulate re-
sponses of endothelial cells to VEGF and basic fibroblast
growth factor via MAPK and PI3K activity (82–84). The
proangiogenic actions of microRNA-126, in part, may be
a result of reduced expression of negative regulators of
angiogenesis, including sprouty-related EVH1 domain-
containing protein 1 that binds and inhibits RAF-1 in-
volved in the Ras/RAF-1/MAP/ERK signaling pathway,
and by silencing PIK3R2/p85-b, a regulatory subunit of
PI3K that results in reduced AKT/PKB activity (83, 84).
MicroRNA-126 is also involved in vascular inflamma-
tion and is highly regulated by proinflammatory cyto-
kines (Table 1). Indeed, microRNA-126 is an inhibitor of
inflammation by negative modulation of VCAM-1 ex-
pression in the resting endothelium (89). Moreover,
BECactivationbycytokinesdecreases levels ofmicroRNA-
126, which is associated with loss in VCAM-1 post-
transcriptional control and promotes leukocyte adherence
to the luminal side of brain endothelium (89) (unpublished
observation). Furthermore, Ets-1 and Ets-2, important
regulators of immune response and of angiogenesis, in-
teract with Ets binding elements upstream of Egfl7/
microRNA-126 (90) and mediate microRNA-126 expres-
sion. In addition, Ets-1 can be induced by TNF-a in the
endothelium and promotes transcription of genes that are
involved in vascular inflammation, including CCL2,
VCAM-1, and matrix metallopeptidase 9 (87). Harris et al.
(89, 90) have proposed that microRNA-126 might act as a
negative feedback loop in TNF-a signal transduction.
Furthermore, the net effect of Ets-1 on vascular inflam-
mationmight, in part, dependon the balance betweenEts-
1–induced proinflammatory factors, such as CCL2 and
VCAM-1, and Ets-1–induced anti-inflammatory factors,
such as microRNA-126.
OTHER microRNAs WITH ROLES IN CEREBRAL
VASCULATURE HOMEOSTASIS
AND PATHOPHYSIOLOGY
High-throughput studies indicate that the brain endothelial
microRNAmilieu facilitates the capacity of cells to respond
to stress and healthy environmental factors. Indeed, lupus
serum and complement protein C5a, which are known to
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negatively regulate brain endothelial integrity (91), as well
as caloric restriction, which is known to positively regulate
brain endothelial integrity (92), induce changes in the levels
of brain endothelial microRNAs (91, 92). This suggests that
brain endothelial microRNA expression not only orches-
trates accurate tuning of gene expression that contributes to
cell homeostasis and BBB integrity, but also might enforce
new gene expression patterns that can influence the path-
ophysiology of disorders that affect CNS vasculature. In
this context, when BECs are treated with homocysteine, a
factor known to disrupt the BBB in vitro (93) and to play a
role in brain damage (94), expression of microRNA-29
family members is significantly increased (93). Mechanisti-
cally, theauthors suggested thatmicroRNA-29bsuppresses
DNA (cytosine-5)-methyltransferase 3b, which leads to in-
creased levels ofmatrixmetallopeptidase 9, a known factor
that disrupts BBB integrity (93). In addition, a recent study
demonstrated that HIV-1 Tat protein up-regulates expres-
sion of brain endothelial microRNA-101, leading to sup-
pression of VE-cadherin protein expression and to
increased brain endothelial barrier permeability (95).
microRNA-150 is another microRNA with roles in brain
endothelial barrier function. Enhanced BBB breakdown
is observed by overexpression of microRNA-150 during
permanent middle cerebral artery occlusion, an animal
stroke model (15). It was reported that microRNA-150
induces enhanced BBB breakdown by directly targeting
brain endothelial tyrosine-protein kinase receptor TIE-2, a
factor involved in maintaining vascular homeostasis and
barrier function (15). Moreover, intracerebroventricular
injection of microRNA-150 inhibitor significantly amelio-
rates BBB disruption in middle cerebral artery occlusion
(15). Of note, brain endothelial microRNAs might also
contribute to molecular processes that contribute to brain
vascular normalization after brain injury. Ge et al. (96, 97)
suggested that increased levels ofmicroRNA-21 could exert
protectiverolesduringBBBdamageasaresultofa traumatic
brain injury animalmodel bymodulating several pathways
concurrently. During traumatic brain injury, increased
levels of microRNA-21 promoted both VEGF and
angiopoietin-1/TIE-2 expression simultaneously, factors
known to increase angiogenesis and cerebrovascular in-
tegrity (96, 97); therefore,microRNA-21 couldbeusedasa
therapeutic strategy to promote neovascularization with
barrier properties during brain injury.
THERAPEUTIC POTENTIAL OF BRAIN
ENDOTHELIAL MICRORNAS FOR CNS DISEASES
MS is a condition with a central neuroinflammatory com-
ponent in which brain endothelial barrier function is
compromised. Furthermore, MS is a chronic autoimmune
CNSdisease that is characterizedbydemyelination, axonal
degeneration, and, ultimately, brain and spinal cord atro-
phy. Studies using gadolinium imaging and MRI analysis
show that BBB disruption occurs in localized brain areas
and is an early event that precedes development of MS
lesions and disease progression (98, 99); however, the
criticalmolecular events in the initiationof cerebrovascular
endothelial dysfunction during MS are largely unknown.
It is noteworthy that recent work demonstrates that
microRNA-155 is focally increased in the active inflam-
matory MS plaques at the neurovascular unit (14, 56) and
activated infiltrative leukocytes (100–102) and might con-
tribute to thepathophysiologyofMS.Ourpioneeringwork
shows that microRNA-155 is highly expressed in confined
areas withMS lesions in the cerebrovascular endothelium.
Our study further suggests that increased levels of brain
endothelial microRNA-155 contribute to early BBB im-
partment observed during neuroinflammation. Indeed,
microRNA-155 levels are rapidly up-regulated in experi-
mental autoimmune encephalomyelitis (EAE), an animal
model for MS, during the relapsing-remitting paraly-
sis course, which are clinical stages with compromised
BBB integrity (14). Moreover, mice that are deficient in
microRNA-155 showpartial resistance to the development
of relapsing-remitting EAE and its associated increases in
BBBpermeability, observations that are consistentwith the
effect of microRNA-155 as a microRNA that promotes in-
flammation in T cells, astrocytes, and brain endothelium in
the CNS (14, 56, 100, 101). However, it still remains elusive
whether the functional consequences of inflammation-
associated microRNA-155 are specific to each of the cell
types involved or whether it represents a conserved gen-
eralized feedback mechanism of the neurovascular unit
leading to cellular uncoupling during neuroinflammation.
Moreover, a recent study further supports brain endo-
thelial microRNA-155 as a potential molecular target for
improving BBB breakdown (103). The authors investi-
gated therapeutic manipulation of microRNA-155 by us-
ing a specific anti-microRNA-155 that was injected
systemically and observed that microRNA-155 inhibition
at an early subacute stage in an animal model of stroke
led to preservation of brain endothelial TJs and barrier
integrity in vivo (103). These studies suggest that brain
endothelial microRNA-155 plays an essential role in neu-
roinflammatory cerebrovascular pathologies that are as-
sociated with disruption of the BBB, and modulation of
microRNA-155 in brain resident cells and brain endothe-
liummayconstitute a novel therapeutic approach forCNS
neuroinflammatory vascular diseases.
Another microRNA therapeutic target for CNS neuro-
inflammatory disorders is brain endothelial microRNA-
146. This microRNA was found predominately in the
cerebral microvasculature of active lesions of MS and is
highly abundant in the brain endothelium that is sur-
rounded by perivascular inflammatory cuffs in the spinal
cord of an EAE relapsing-remitting mice model (74). Mice
that are deficient for microRNA-146 are developmentally
normal at birth but acquired chronic inflammation around
5–6mo of age (75) and had enhanced expression of several
inflammatory genes, including Vcam-1, Icam-1, Sele, Mcp-
1, and Egr1/3 after challenge with the proinflammatory
cytokine IL-1b (75). Wu et al. (74) demonstrated that
microRNA-146 negatively modulated the NF-kB signaling
pathway in cultured human brain endothelium via stifling
multiple genes, including IL-1 receptor–associatedkinase 1,
TNF receptor–associated factor 6 protein, nuclear factor of
activatedT cells 5, andRhoA,which regulatesVCAM1and
CCL2proteinexpression, and, therefore,directly resulted in
decreased leukocyte adhesion to inflamed blood vessels.
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Another study has analyzed the therapeutic manipula-
tion of brain endothelial microRNA-98 and Let-7g-3p to
prevent BBB dysfunction in neuroinflammation. In this
study, the authors identified 2 potential targets, CCL2 and
CCL5,bywhichmicroRNA-98andLet-7g-3pmayregulate
leukocyte adhesion (34). These studies suggest that a brain
endothelial microRNA therapeutic strategy aimed at ame-
liorating BBB dysfunction during neuroinflammation may
be beneficiated as a result of microRNAs concomitantly
modulating several molecular and cellular processes im-
plicated in neuroinflammation.
CONCLUSIONS
Cytokines regulate the expression of brain endothelial
microRNAs that either promote or inhibit inflammatory
pathways to orchestrate neuroinflammation at the cerebro-
vascular bed. Depending on the strength andduration of the
inflammatory stimuli, brain endothelial microRNAsmay ei-
ther regulategeneexpression tocounteractcytokinesignaling
tomaintain the quiescent state or promote a gene expression
profile towardanactivatedcerebrovascularendotheliumthat
could lead to BBBbreakdown.Here,wepresented that some
cytokine-responsive brain endothelial microRNAs can be
grouped into coexpressed microRNA clusters and families
previously implicated in molecular and cellular processes of
angiogenesis. Nevertheless, it remains to be determined
whether these alteredmicroRNAclusters and familiesmight
participate in increased angiogenesis that has been observed
in neurologic conditions affected by neuroinflammation.
Further research in brain endothelial microRNAs will
no doubt increase our understanding of the molecular
processes that regulate BBB integrity in health and disease,
which will tremendously benefit the development of
microRNA therapeutic strategies aimed at ameliorating
BBB dysfunction during neuroinflammation. Indeed, sev-
eral preclinical and clinical trials have started microRNA-
based therapeutics for many types of disease, including
cancers that affect theCNSsuchasglioblastomas (104).Use
of systemic administrationof lockednucleic acid–modified
oligonucleotidemight be apromising form for the delivery
of inhibitory microRNAs to the CNS (105), including the
brain vasculature (103), which could be used to ameliorate
or prevent CNS disorders inwhichmicroRNAs play a key
pathogenic role (106). In the near future, a major challenge
will be to define the spatio-temporal activities of brain en-
dothelial microRNAs andwhethermicroRNA therapeutic
strategies are targeted to ameliorate BBB dysfunction
during transient or chronic CNS disorders.
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